Clinical Trial Update: To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing the immunogenicity and safety of GC1107 administered intramuscularly in healthy adults for bacterial infections; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• GC1107

Snippet

Sponsor: Green Cross Corporation | Conditions: Bacterial Infections | Phase 3 | Status: COMPLETED